Skip to content

Oral and Olfactory Complications of Recovered COVID-19 Patients

Oral and Olfactory Complications of Recovered COVID-19 Patients: A Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04791436
Enrollment
402
Registered
2021-03-10
Start date
2021-05-01
Completion date
2025-05-28
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysgeusia, Olfactory Disorder, Oral Complication

Keywords

COVID-19, Oral Manifestations, Olfactory Manifestations

Brief summary

This cohort study aims to investigate the long-standing chemosensory disorders and oral manifestation after recovery of the COVID-19 illness. A correlation between the long-standing symptoms and the COVID-19 severity grade will be very important to understand and clarify the aetiology of these symptoms.

Detailed description

This prospective cohort study aims to investigate the long-standing chemosensory disorders and oral manifestation after recovery of the COVID-19 illness. A correlation between the long-standing symptoms and the COVID-19 severity grade will be very important to understand and clarify the aetiology of these symptoms. Study objectives: 1. To describe the frequency and severity of oral signs and chemosensory disorders that persist after the recovery of COVID-19 and to examine whether taste disorders can be discriminated into an- or hypogeusia and an- or hyposmia. 2. To report any correlation between the severity grade of COVID-19 and the resulting standing symptoms. 3. To describe the oral microbiome after infection with COVID-19 and to describe possible changes in comparison to normal healthy individuals. Clinical and -if indicated- radiological examination to assess the long-term oral and chemosensory impairment and complaints of COVID-19 patients after their recovery shall be performed in an interdisciplinary setting of Maxillofacial Surgery, ENT and Medical Microbiology. The study subjects will be divided into three groups according to the severity grade of illness: non-hospitalized, hospitalized, and intensive care patients. All adult COVID-19 recovery patients (exceeding the age of 18) will be included in the study. The time between illness and study recruitment shall be at least 3 months. Exclusion criteria are psychiatric or neurological diseases, previous trauma, surgery or radiotherapy in the oral or nasal cavities, pre-existing taste or smell dysfunctions or chronic rhinosinusitis. The study variables include age, sex, co-morbidities, possible causes of exclusion from the study. The oral health assessment will be performed by examination of: periodontal status, assessment of oral lesions, a radiological examination by using panoramic x-ray if clinically indicated, photo documentation, objective evaluation of the olfactory and gustatory functions with psychophysical tests. The gustatory and olfactory function will be tested by using the combined Burghart Screening 12 test containing smelling sticks and taste strips (Fa. MediSense, Groningen, Netherlands). Evaluation of taste and smell is performed by offering the sticks/strips and demand a forced multiple choice.

Interventions

DIAGNOSTIC_TESTGustatory and olfactory function test

The gustatory and olfactory function will be tested by using the combined Burghart Screening 12 test containing smelling sticks and taste strips (Fa. MediSense, Groningen, Netherlands). Evaluation of taste and smell is performed by offering the sticks/strips and demand a forced multiple choice.

DIAGNOSTIC_TESTMolecular assessment of saliva

Saliva samples will be taken for molecular biological determination of the oral microbiome. The microbiome is determined at the Institute for Medical Microbiology by 16s-rRNA gene analysis with Next Generation Sequencing and bioinformatics.

Sponsors

Masaryk University
CollaboratorOTHER
University of Kiel
CollaboratorOTHER
University of Giessen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All adult COVID-19 recovery patients (exceeding the age of 18) will be included in the study. The time between illness and study recruitment shall be at least 3 months.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Periodontal healthAt least 3 months after recovery of COVID-19Community Periodontal Index (CPI) of the World Health Organization (WHO) will be used to assess periodontal health (continuous variable)
Oral mucocutaneous lesionsAt least 3 months after recovery of COVID-19An intraoral examination will be carried out to assess the presence of any mucocutaneous lesions (dichotomous variable)
Gustatory functionAt least 3 months after recovery of COVID-19Burghart Sniffin' Sticks Screening 12 Test will be used to assess gustatory function (continuous variable)
Olfactory functionAt least 3 months after recovery of COVID-19Burghart Sniffin' Sticks Screening 12 Test will be used to assess olfactory function (continuous variable)

Countries

Germany

Contacts

Primary ContactSameh Attia, MSc
Sameh.Attia@dentist.med.uni-giessen.de00496419946110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026